FDA Approves Surgical Implant for Chronic Sinusitis

The FDA has approved a surgical implant for the treatment of chronic sinusitis. The implant is called Propel mini. It is intended to be implanted during endoscopic nasal-sinus surgery (a common surgery which removes excess and abnormal sinus tissue). The implant not only claims to prop the sinuses open but delivers a local dose of mometasone furoate, a steroid medication which reduces inflammation. This is a smaller version of a previously approved, larger implant called Propel. The implant dissolves over time so it does not need to be surgically removed at a later date.

Stay Up To Date: Subscribe to my free newsletter

and follow me on Twitter or Facebook.